U.S. Government Helps Device Firms Access China's Healthcare Market
This article was originally published in PharmAsia News
Executive Summary
The U.S. Trade and Development Agency will travel to China later this month as the first step in facilitating a new partnership involving U.S. health care companies, the U.S. government and China's government
You may also be interested in...
Chinese President Pledges China Will Not Discriminate Against U.S. Businesses; Broad Healthcare Partnership Unveiled
WASHINGTON, D.C. - In introducing China President Hu Jintao at a luncheon reception Jan. 20, former Secretary of State Henry Kissinger said that if China and the U.S. work together most of the problems between the two nations "will find a creative solution," but if the two nations can't do that, then "there is no possibility for one side or the other achieving a success over the other.
China Signals Need For Private Investment To Support Its Healthcare Reforms; Private Insurance Options Likely To Widen
SHANGHAI - China recently lifted a ban on foreign investment in medical institutes to support its $124 billion healthcare reforms and the establishment of wholly foreign-owned hospitals and clinics. The move by the Chinese government is being read as a signal that China may open more of the country's healthcare industry to foreign investment
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).